|
US6828415B2
(en)
*
|
1993-02-19 |
2004-12-07 |
Zentaris Gmbh |
Oligopeptide lyophilisate, their preparation and use
|
|
WO2000025820A1
(en)
*
|
1998-11-04 |
2000-05-11 |
Pharmadigm, Inc. |
Compounds and methods for genetic immunization
|
|
AU2150900A
(en)
*
|
1998-11-16 |
2000-06-05 |
Board Of Regents, The University Of Texas System |
Hiv-specific t-cell induction
|
|
ES2246826T3
(es)
*
|
1999-01-28 |
2006-03-01 |
Stichting Biomedical Primate Research Center |
Composicion y procedimiento para obtener inmunizacion especifica contra uno o mas antigenos usando diferentes vectores recombinantes.
|
|
WO2001077157A2
(en)
|
2000-04-06 |
2001-10-18 |
University Of Iowa Research Foundation |
FULL-LENGTH gb virus c (HEPATITIS G VIRUS) RNA TRANSCRIPTS ARE INFECTIOUS IN PRIMARY CD4 POSITIVE T CELLS AND METHODS OF TREATING HIV
|
|
EP1305435B1
(en)
*
|
2000-07-27 |
2007-12-19 |
The Trustees Of The University Of Pennsylvania |
Use of herpes simplex virus glycoprotein d to suppress immune responses
|
|
KR100369237B1
(ko)
*
|
2000-09-14 |
2003-01-24 |
김원중 |
음식물 쓰레기와 축산폐수의 혼합처리 방법
|
|
GB0023008D0
(en)
*
|
2000-09-20 |
2000-11-01 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
US6867000B2
(en)
*
|
2000-12-07 |
2005-03-15 |
Wyeth Holdings Corporation |
Method of enhancing immune responses to herpes
|
|
AU2003216852B2
(en)
*
|
2002-03-19 |
2008-09-11 |
Glaxo Group Limited |
Imidazoquinolineamines as adjuvants in HIV DNA vaccination
|
|
CA2492598C
(en)
*
|
2002-07-18 |
2013-12-17 |
University Of Washington |
Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same
|
|
AU2003287216A1
(en)
*
|
2002-10-24 |
2004-05-13 |
Sarah George |
Gb virus c and methods of treating viral infections
|
|
EP1998800A2
(en)
|
2006-01-18 |
2008-12-10 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
|
CA2739581A1
(en)
|
2008-10-06 |
2010-04-15 |
University Of Chicago |
Compositions and methods related to bacterial eap, emp, and/or adsa proteins
|
|
US9044447B2
(en)
|
2009-04-03 |
2015-06-02 |
University Of Washington |
Antigenic peptide of HSV-2 and methods for using same
|
|
WO2011127032A1
(en)
|
2010-04-05 |
2011-10-13 |
University Of Chicago |
Compositions and methods related to protein a (spa) antibodies as an enhancer of immune response
|
|
JP5789250B2
(ja)
|
2009-04-03 |
2015-10-07 |
ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ |
プロテインＡ（ＳｐＡ）変種に関連する組成物および方法
|
|
KR101746872B1
(ko)
*
|
2009-05-22 |
2017-06-14 |
제노시아 바이오사이언스, 인크. |
단순 포진 바이러스 유형 2에 대한 백신: 면역 반응을 유도하는 조성물 및 방법
|
|
CA2803298C
(en)
|
2010-07-02 |
2020-07-14 |
The University Of Chicago |
Compositions and methods related to protein a (spa) variants
|
|
EP2614074A1
(en)
|
2010-09-09 |
2013-07-17 |
The University of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
|
US9782474B2
(en)
|
2010-11-24 |
2017-10-10 |
Genocea Biosciences, Inc. |
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
|
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
|
US9624273B2
(en)
|
2011-11-23 |
2017-04-18 |
Genocea Biosciences, Inc. |
Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
|
|
NZ702285A
(en)
|
2012-04-26 |
2016-07-29 |
Univ Chicago |
Staphylococcal coagulase antigens and methods of their use
|
|
WO2018064232A1
(en)
|
2016-09-28 |
2018-04-05 |
Genocea Biosciences, Inc. |
Methods and compositions for treating herpes
|
|
US11413336B2
(en)
|
2018-03-23 |
2022-08-16 |
Board Of Regents, The University Of Texas System |
Coccidioides antigens and methods of their use
|